August 16th, 2023– iCAD announced it signed an amendment to its development and commercialization agreement with Google Health, which will enable iCAD to integrate Google’s AI technology with its ProFound Breast Health Suite for 2D Mammography for use worldwide upon regulatory approval as an independent reader for breast cancer screening for 20 years.
ProFound Detection is a high-performance, deep learning cancer detection solution that is clinically proven to improve detection and workflow efficiency for radiologists reading mammography. Available for both 2D and 3D mammography, it rapidly and accurately analyzes each mammography image, and alerts radiologists of suspicious areas that may warrant a closer look. A growing body of evidence confirms ProFound Detection improves accuracy and efficiency for radiologists, empowering them to find more cancers while reducing the rate of false positives and unnecessary recalls.
iCAD signed a strategic development and commercialization agreement with Google Health in November 2022 to integrate Google’s AI technology into iCAD’s leading-edge portfolio of breast imaging AI solutions, including ProFound Detection.